恩华药业：第七届监事会第三次会议决议公告

Core Points - Enhua Pharmaceutical announced the approval of its 2025 semi-annual report and the conditions for the first unlock period of its 2024 restricted stock incentive plan [1] Group 1 - The seventh supervisory board of Enhua Pharmaceutical held its third meeting and reviewed the full text and summary of the 2025 semi-annual report [1] - The board also approved the proposal regarding the achievement of the unlock conditions for the first unlock period of the restricted stock incentive plan for 2024 [1]